Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Return on Sales: 2011-2025

Historic Return on Sales for Heron Therapeutics (HRTX) over the last 10 years, with Sep 2025 value amounting to 0.01%.

  • Heron Therapeutics' Return on Sales rose 20.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 20.00%. This contributed to the annual value of -0.10% for FY2024, which is 78.00% up from last year.
  • As of Q3 2025, Heron Therapeutics' Return on Sales stood at 0.01%, which was up 25.11% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Heron Therapeutics' Return on Sales ranged from a high of 0.01% in Q3 2025 and a low of -2.80% during Q2 2021.
  • Over the past 3 years, Heron Therapeutics' median Return on Sales value was -0.34% (recorded in 2024), while the average stood at -0.50%.
  • Per our database at Business Quant, Heron Therapeutics' Return on Sales plummeted by 131bps in 2021 and then spiked by 127bps in 2023.
  • Heron Therapeutics' Return on Sales (Quarterly) stood at -2.52% in 2021, then spiked by 90bps to -1.62% in 2022, then skyrocketed by 75bps to -0.87% in 2023, then skyrocketed by 79bps to -0.08% in 2024, then grew by 20bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, 0.01% for Q2 2025, and -0.02% during Q1 2025.